EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

DNA sequencing for microbial surveillance in cystic fibrosis airways: advances, challenges, and clinical translation

Jessica A P Carlson-Jones iD, Thomas R Goddard iD, Bhavya Papudeshi iD, Vijini Mallawaarachchi iD, Katrine L Whiteson iD, Morgyn S Warner iD, Judith M Morton iD, Hubertus P A Jersmann iD, Robert A Edwards iD

Clinical Microbiology Reviews · 2026

DOI: 10.1128/cmr.00352-25 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, 2026. Verfasst von Jessica A P Carlson-Jones und 8 weiteren Autor:innen. Beteiligte Einrichtung: Flinders Accelerator for Microbiome Exploration, College of Science and Engineering, Flinders University, Adelaide, South Australia, Australia. Hauptthemen laut MEDLINE: Cystic Fibrosis, Microbiota, Sequence Analysis, DNA, Respiratory System. Die Arbeit nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Education and Training | Australian Research Council (ARC), Women's & Children's Hospital Foundation, National Health and Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA sequencing has revolutionized microbial surveillance in cystic fibrosis (CF), transforming pathogen identification from culture-dependent to total microbial community identification using molecular-based approaches. Techniques such as 16S rRNA gene sequencing have uncovered the complexity of the CF airway microbiome, while shotgun metagenomics, metatranscriptomics, and viromics now provide strain-level, functional, and viral insights beyond bacterial identification. Despite these advances, key technical and logistical challenges remain, including the processing of high-viscosity sputum samples, overwhelming host DNA contamination, managing large data sets, and the integration of complex bioinformatic outputs into clinical workflows. Emerging innovations such as host DNA depletion protocols, targeted enrichment panels, and adaptive sampling on Oxford Nanopore platforms are helping to overcome these barriers, improving microbial recovery and sequencing efficiency. As cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies are changing the lives of people with cystic fibrosis (pwCF), sequencing offers an unprecedented opportunity to track potential microbial adaptation in response. This review investigates current advances, limitations, and translational opportunities in DNA sequencing for CF airway microbiome surveillance, highlighting how these technologies can help reshape research and clinical microbiology in the post-modulator era.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisMicrobiotaSequence Analysis, DNARespiratory SystemHumansMetagenomicsSputumBacteria

Stichwörter der Autor:innen

DNA sequencingcystic fibrosisdiagnosticsmetagenomicsrespiratory pathogens

Autor:innen und Institutionen

  • Flinders Accelerator for Microbiome Exploration, College of Science and Engineering, Flinders University, Adelaide, South Australia, Australia.
  • Department of Respiratory and Sleep Medicine, Women's and Children's Hospital, Adelaide, South Australia, Australia.
  • College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
  • Faculty of Health and Medical Sciences, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.
  • Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, California, USA.
  • Microbiology & Infectious Diseases Directorate, SA Pathology, Adelaide, South Australia, Australia.

ORCID-Profile: Jessica A P Carlson-Jones, Thomas R Goddard, Bhavya Papudeshi, Vijini Mallawaarachchi, Katrine L Whiteson, Morgyn S Warner, Judith M Morton, Hubertus P A Jersmann, Robert A Edwards

Förderung

  • Department of Education and Training | Australian Research Council (ARC)
  • Women's & Children's Hospital Foundation
  • National Health and Medical Research Council
  • CALHN CEO Clinical Rapid Implementation Project Scheme

Zitieren

APA

Carlson-Jones, J. A. P., Goddard, T. R., Papudeshi, B., Mallawaarachchi, V., Whiteson, K. L., Warner, M. S., Morton, J. M., Jersmann, H. P. A., & Edwards, R. A. (2026). DNA sequencing for microbial surveillance in cystic fibrosis airways: advances, challenges, and clinical translation. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00352-25

Vancouver

Carlson-Jones JAP, Goddard TR, Papudeshi B, Mallawaarachchi V, Whiteson KL, Warner MS, et al. DNA sequencing for microbial surveillance in cystic fibrosis airways: advances, challenges, and clinical translation. Clinical Microbiology Reviews. 2026. doi:10.1128/cmr.00352-25

BibTeX
@article{CarlsonJones2026,
  author = {Carlson-Jones, Jessica A P and Goddard, Thomas R and Papudeshi, Bhavya and Mallawaarachchi, Vijini and Whiteson, Katrine L and Warner, Morgyn S and Morton, Judith M and Jersmann, Hubertus P A and Edwards, Robert A},
  title = {DNA sequencing for microbial surveillance in cystic fibrosis airways: advances, challenges, and clinical translation},
  journal = {Clinical Microbiology Reviews},
  year = {2026},
  doi = {10.1128/cmr.00352-25}
}
Kostenlos starten →